Log in
(Ad)
If you're happy with stocks yielding you 4% or 5% a year, you don't need this. But if you want to see how we built a portfolio that now pays us a 67% cash on cash return - with no leverage, options, or gimmicks.

LON:GNS - Genus Share Price, Forecast & News

GBX 3,068
-32.00 (-1.03 %)
(As of 01/24/2020 03:30 AM ET)
Add
Compare
Today's Range
3,052
Now: GBX 3,068▼
3,144
50-Day Range
3,068
MA: GBX 3,154.64▼
3,246
52-Week Range
2,122
Now: GBX 3,068▼
3,358
Volume45,474 shs
Average Volume78,154 shs
Market Capitalization£2.00 billion
P/E Ratio257.82
Dividend Yield0.90%
BetaN/A
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos, which are delivered through artificial insemination to breed dairy and beef cattle with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Read More…

Industry, Sector and Symbol

Stock Exchange LON
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolLON:GNS
Previous Symbol
CUSIPN/A
CIKN/A
Webhttp://www.genusplc.com/
Phone+44-1256-347100

Debt

Debt-to-Equity Ratio21.92
Current Ratio2.01
Quick Ratio1.19

Price-To-Earnings

Trailing P/E Ratio257.82
Forward P/E Ratio0.38
P/E GrowthN/A

Sales & Book Value

Annual Sales£488.50 million
Price / Sales4.09
Cash FlowGBX 46.96 per share
Price / Cash Flow65.34
Book ValueGBX 779 per share
Price / Book3.94

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees2,900
Outstanding Shares65,079,900
Market Cap£2.00 billion
Next Earnings Date2/27/2020 (Estimated)
OptionableNot Optionable

Receive GNS News and Ratings via Email

Sign-up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.

LSE:GNS Rates by TradingView

(Ad)

Paul Mampilly correctly predicted every bull and bear market over the last two decades. He made millions. His new "Dow 100,000" prediction is his boldest yet. Even more stunning... Paul reveals how you could make millions as it unfolds.

Genus (LON:GNS) Frequently Asked Questions

What is Genus' stock symbol?

Genus trades on the London Stock Exchange (LON) under the ticker symbol "GNS."

How often does Genus pay dividends? What is the dividend yield for Genus?

Genus declared a dividend on Thursday, September 5th. Stockholders of record on Thursday, November 7th will be paid a dividend of GBX 18.80 per share on Friday, November 29th. This represents a dividend yield of 0.68%. The ex-dividend date of this dividend is Thursday, November 7th. This is an increase from Genus's previous dividend of $8.90. The official announcement can be viewed at this link. View Genus' Dividend History.

When is Genus' next earnings date?

Genus is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Genus.

What price target have analysts set for GNS?

6 Wall Street analysts have issued 12 month price objectives for Genus' stock. Their forecasts range from GBX 2,685 to GBX 3,450. On average, they anticipate Genus' share price to reach GBX 3,177.83 in the next year. This suggests a possible upside of 3.6% from the stock's current price. View Analyst Price Targets for Genus.

What is the consensus analysts' recommendation for Genus?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genus in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genus.

Has Genus been receiving favorable news coverage?

News articles about GNS stock have been trending extremely negative on Friday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Genus earned a news sentiment score of -5.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Genus.

Who are some of Genus' key competitors?

What other stocks do shareholders of Genus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco Plc Ads (BATS), Dairy Crest Group (DCG), Debenhams (DEB), Diageo (DGE), Experian (EXPN) and Ferguson (FERG).

Who are Genus' key executives?

Genus' management team includes the folowing people:
  • Mr. Karim Bitar, CEO & Exec. Director (Age 54)
  • Mr. Stephen Wilson, Group Fin. Director & Exec. Director (Age 59)
  • Dr. Jonathan Lightner, Chief of R&D and Scientific Officer
  • Mr. Dan Hartley, Group Gen. Counsel & Company Sec.
  • Ms. Angelle R. Rosata, Group HR Director

How do I buy shares of Genus?

Shares of GNS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Genus' stock price today?

One share of GNS stock can currently be purchased for approximately GBX 3,068.

How big of a company is Genus?

Genus has a market capitalization of £2.00 billion and generates £488.50 million in revenue each year. Genus employs 2,900 workers across the globe.View Additional Information About Genus.

What is Genus' official website?

The official website for Genus is http://www.genusplc.com/.

How can I contact Genus?

Genus' mailing address is Matrix House, Basing View, BASINGSTOKE, RG21 4DZ, United Kingdom. The company can be reached via phone at +44-1256-347100.


MarketBeat Community Rating for Genus (LON GNS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  328 (Vote Outperform)
Underperform Votes:  277 (Vote Underperform)
Total Votes:  605
MarketBeat's community ratings are surveys of what our community members think about Genus and other stocks. Vote "Outperform" if you believe GNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Featured Article: Average Daily Trade Volume - What You Need to Know
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel